114 related articles for article (PubMed ID: 15736300)
1. Enrichment of the R77C alpha-sarcoglycan gene mutation in Finnish LGMD2D patients.
Hackman P; Juvonen V; Sarparanta J; Penttinen M; Aärimaa T; Uusitalo M; Auranen M; Pihko H; Alén R; Junes M; Lönnqvist T; Kalimo H; Udd B
Muscle Nerve; 2005 Feb; 31(2):199-204. PubMed ID: 15736300
[TBL] [Abstract][Full Text] [Related]
2. Mannosidase I inhibition rescues the human alpha-sarcoglycan R77C recurrent mutation.
Bartoli M; Gicquel E; Barrault L; Soheili T; Malissen M; Malissen B; Vincent-Lacaze N; Perez N; Udd B; Danos O; Richard I
Hum Mol Genet; 2008 May; 17(9):1214-21. PubMed ID: 18252745
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel SGCA missense mutation in a case of limb-girdle muscular dystrophy 2D with the absence of four sarcoglycan proteins.
Lu Y; Song X; Ji G; Wu H; Li D; Sun S
Neuropathology; 2019 Jun; 39(3):207-211. PubMed ID: 30989758
[TBL] [Abstract][Full Text] [Related]
4. Genetic heterogeneity within a consanguineous family involving the LGMD 2D and the LGMD 2C genes.
Fendri K; Kefi M; Hentati F; Amouri R
Neuromuscul Disord; 2006 May; 16(5):316-20. PubMed ID: 16616845
[TBL] [Abstract][Full Text] [Related]
5. Founder mutation for α-sarcoglycan-LGMD2D in a Magdalen Islands Acadian cluster.
Tétreault M; Srour M; Allyson J; Thiffault I; Loisel L; Robitaille Y; Bouchard JP; Brais B
Can J Neurol Sci; 2011 Sep; 38(5):747-52. PubMed ID: 21856579
[TBL] [Abstract][Full Text] [Related]
6. The first case of primary alpha-sarcoglycanopathy identified in Albania, in two siblings with homozygous alpha-sarcoglycan mutation.
Babameto-Laku A; Tabaku M; Tashko V; Cikuli M; Mokini V
Genet Couns; 2011; 22(4):377-83. PubMed ID: 22303798
[TBL] [Abstract][Full Text] [Related]
7. Probable high prevalence of limb-girdle muscular dystrophy type 2D in Taiwan.
Liang WC; Chou PC; Hung CC; Su YN; Kan TM; Chen WZ; Hayashi YK; Nishino I; Jong YJ
J Neurol Sci; 2016 Mar; 362():304-8. PubMed ID: 26944168
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of mutations in sarcoglycan genes in the Mumbai region of western India: high prevalence of 525del T.
Khadilkar SV; Singh RK; Hegde M; Urtizberea A; Love DR; Chong B
Neurol India; 2009; 57(4):406-10. PubMed ID: 19770540
[TBL] [Abstract][Full Text] [Related]
9. Lack of toxicity of alpha-sarcoglycan overexpression supports clinical gene transfer trial in LGMD2D.
Rodino-Klapac LR; Lee JS; Mulligan RC; Clark KR; Mendell JR
Neurology; 2008 Jul; 71(4):240-7. PubMed ID: 18525034
[TBL] [Abstract][Full Text] [Related]
10. C283Y gamma-sarcoglycan gene mutation in the Bulgarian Roma (Gypsy) population: prevalence study and carrier screening in a high-risk community.
Georgieva B; Todorova A; Tournev I; Mitev V; Kremensky I
Clin Genet; 2004 Nov; 66(5):467-72. PubMed ID: 15479193
[TBL] [Abstract][Full Text] [Related]
11. Preclinical Systemic Delivery of Adeno-Associated α-Sarcoglycan Gene Transfer for Limb-Girdle Muscular Dystrophy.
Griffin DA; Pozsgai ER; Heller KN; Potter RA; Peterson EL; Rodino-Klapac LR
Hum Gene Ther; 2021 Apr; 32(7-8):390-404. PubMed ID: 33349138
[TBL] [Abstract][Full Text] [Related]
12. Sarcoglycanopathies and the risk of undetected deletion alleles in diagnosis.
White SJ; Uitte de Willige S; Verbove D; Politano L; Ginjaar I; Breuning MH; den Dunnen JT
Hum Mutat; 2005 Jul; 26(1):59. PubMed ID: 15954112
[TBL] [Abstract][Full Text] [Related]
13. Mutational spectrum of autosomal recessive limb-girdle muscular dystrophies in a cohort of 112 Iranian patients and reporting of a possible founder effect.
Mojbafan M; Bahmani R; Bagheri SD; Sharifi Z; Zeinali S
Orphanet J Rare Dis; 2020 Jan; 15(1):14. PubMed ID: 31937337
[TBL] [Abstract][Full Text] [Related]
14. [Early onset adhalinopathy (LGMD2D) mimicking congenital muscular dystrophy].
Castro-Gago M; Novo-Rodríguez MI; Pintos-Martínez E; Gallano P; Eirís-Puñal J
Rev Neurol; 2001 Apr 1-15; 32(7):631-5. PubMed ID: 11391490
[TBL] [Abstract][Full Text] [Related]
15. A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C.
Herson S; Hentati F; Rigolet A; Behin A; Romero NB; Leturcq F; Laforêt P; Maisonobe T; Amouri R; Haddad H; Audit M; Montus M; Masurier C; Gjata B; Georger C; Cheraï M; Carlier P; Hogrel JY; Herson A; Allenbach Y; Lemoine FM; Klatzmann D; Sweeney HL; Mulligan RC; Eymard B; Caizergues D; Voït T; Benveniste O
Brain; 2012 Feb; 135(Pt 2):483-92. PubMed ID: 22240777
[TBL] [Abstract][Full Text] [Related]
16. Revised spectrum of mutations in sarcoglycanopathies.
Trabelsi M; Kavian N; Daoud F; Commere V; Deburgrave N; Beugnet C; Llense S; Barbot JC; Vasson A; Kaplan JC; Leturcq F; Chelly J
Eur J Hum Genet; 2008 Jul; 16(7):793-803. PubMed ID: 18285821
[TBL] [Abstract][Full Text] [Related]
17. Two siblings with limb-girdle muscular dystrophy type 2E responsive to deflazacort.
Wong-Kisiel LC; Kuntz NL
Neuromuscul Disord; 2010 Feb; 20(2):122-4. PubMed ID: 20071171
[TBL] [Abstract][Full Text] [Related]
18. An autosomal recessive limb girdle muscular dystrophy (LGMD2) with mild mental retardation is allelic to Walker-Warburg syndrome (WWS) caused by a mutation in the POMT1 gene.
Balci B; Uyanik G; Dincer P; Gross C; Willer T; Talim B; Haliloglu G; Kale G; Hehr U; Winkler J; Topaloğlu H
Neuromuscul Disord; 2005 Apr; 15(4):271-5. PubMed ID: 15792865
[TBL] [Abstract][Full Text] [Related]
19. Homozygous microdeletion of chromosome 4q11-q12 causes severe limb-girdle muscular dystrophy type 2E with joint hyperlaxity and contractures.
Kaindl AM; Jakubiczka S; Lücke T; Bartsch O; Weis J; Stoltenburg-Didinger G; Aksu F; Oexle K; Koehler K; Huebner A
Hum Mutat; 2005 Sep; 26(3):279-80. PubMed ID: 16088906
[TBL] [Abstract][Full Text] [Related]
20. Precise Correction of Disease Mutations in Induced Pluripotent Stem Cells Derived From Patients With Limb Girdle Muscular Dystrophy.
Turan S; Farruggio AP; Srifa W; Day JW; Calos MP
Mol Ther; 2016 Apr; 24(4):685-96. PubMed ID: 26916285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
